Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas C P Cross

Showing results (131-140 of 221) with videos related to

Pageof 23
Sort By:
Blood|December 15, 2005
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alphaAmy V Jones, Richard T Silver, Katherine Waghorn, et al.
Haematologica|December 10, 2009
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic contextLaura Chiecchio, Gian Paolo Dagrada, Ashraf H Ibrahim, et al.
Clinical Chemistry|February 20, 2010
Interlaboratory diagnostic validation of conformation-sensitive capillary electrophoresis for mutation scanningChristopher J Mattocks, Gemma Watkins, Daniel Ward, et al.
Blood|May 13, 2011
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNetSimona Soverini, Andreas Hochhaus, Franck E Nicolini, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Haematologica|January 29, 2010
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysisPhilipp Erben, Darko Gosenca, Martin C Müller, et al.
Cancers|February 10, 2024
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in <i>KIT</i> D816V-Negative Advanced Systemic MastocytosisNicole Naumann, Martina Rudelius, Johannes Lübke, et al.
British Journal of Haematology|January 24, 2017
Guideline for the investigation and management of eosinophiliaNauman M Butt, Jonathan Lambert, Sahra Ali, et al.
Blood|February 7, 2025
The JAK2 46/1 haplotype influences PD-L1 expressionGonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, et al.
Blood|January 13, 2011
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like diseaseChristian Elling, Philipp Erben, Christoph Walz, et al.
Pageof 23

Showing results (131-140 of 221) with videos related to

Sort By:
Pageof 23
Blood|December 15, 2005
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alphaAmy V Jones, Richard T Silver, Katherine Waghorn, et al.
Haematologica|December 10, 2009
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic contextLaura Chiecchio, Gian Paolo Dagrada, Ashraf H Ibrahim, et al.
Clinical Chemistry|February 20, 2010
Interlaboratory diagnostic validation of conformation-sensitive capillary electrophoresis for mutation scanningChristopher J Mattocks, Gemma Watkins, Daniel Ward, et al.
Blood|May 13, 2011
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNetSimona Soverini, Andreas Hochhaus, Franck E Nicolini, et al.
Haematologica|March 4, 2017
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasmMohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, et al.
Haematologica|January 29, 2010
Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysisPhilipp Erben, Darko Gosenca, Martin C Müller, et al.
Cancers|February 10, 2024
Poor Applicability of Currently Available Prognostic Scoring Systems for Prediction of Outcome in <i>KIT</i> D816V-Negative Advanced Systemic MastocytosisNicole Naumann, Martina Rudelius, Johannes Lübke, et al.
British Journal of Haematology|January 24, 2017
Guideline for the investigation and management of eosinophiliaNauman M Butt, Jonathan Lambert, Sahra Ali, et al.
Blood|February 7, 2025
The JAK2 46/1 haplotype influences PD-L1 expressionGonzalo Carreño-Tarragona, María Tiana, Raquel Rouco, et al.
Blood|January 13, 2011
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like diseaseChristian Elling, Philipp Erben, Christoph Walz, et al.
Pageof 23